CHM chimeric therapeutics limited

Ann: $6.6 million Placement to advance clinical trial pipeline, page-52

  1. 868 Posts.
    lightbulb Created with Sketch. 188
    CHM needed funding and now has funding. The carry on about being diluted when the retail shareholders didn’t subscribe full amount in previous raises is hilarious. At this end of the market, risk is high. Way more important to have funding available to continue progressing pipeline than to be in administration
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.747M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.858K 619.3K

Buyers (Bids)

No. Vol. Price($)
66 58647032 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 107164382 32
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.